Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase.

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Abstract Text:

Masaomi Nangaku,Ichiro Kojima,Tetsuhiro Tanaka,Takamoto Ohse,Hideki Kato,Toshiro Fujita,Masaomi Nangaku,Ichiro Kojima,Tetsuhiro Tanaka,Takamoto Ohse,Hideki Kato,Toshiro Fujita,Masaomi Nangaku,Ichiro Kojima,Tetsuhiro Tanaka,Takamoto Ohse,Hideki Kato,Toshiro Fujita,

Tissue hypoxia occurs when local metabolism is disturbed by an imbalance between oxygen supply and consumption. This condition can lead to a variety of serious ischemic disorders, including a number of important cardiovascular diseases. In the search for therapeutic approaches, focused modalities which specifically target hypoxia have been particularly sought. These efforts would profit from the ability to utilize the mechanisms by which cells adjust to hypoxic conditions. At the center of the cellular response to hypoxia is hypoxia-inducible factor, HIF. This factor is composed of two subunits, an oxygen-sensitive HIF-alpha subunit and a constitutively expressed HIF-beta subunit. Intracellular accumulation of HIF induces the coordinated expression of a number of adaptive genes against hypoxic insult. Because activation of HIF is a promising therapeutic modality for ischemic cardiovascular disease, recent studies have focused on the development of HIF stimulators. HIF levels are regulated by prolyl hydroxylation and asparaginyl hydroxylation of the HIF-alpha subunit. To date, a single HIF asparaginyl hydroxylase has been identified, factor inhibiting HIF (FIH), whereas the mammalian genome encodes three closely related proteins that have HIF prolyl hydroxylase activity, PHD1, PHD2 and PHD3. Recent patents have disclosed methods for identifying modulators of HIF or PHD as well as novel compounds with properties of HIF modulation or prolyl hydroxylase inhibition. This review highlights the identification of novel HIF stabilizers as specific molecularly targeted therapies against cardiovascular disease.

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Publishing Authors By Initials

M Nangaku,I Kojima,T Tanaka,T Ohse,H Kato,T Fujita,M Nangaku,I Kojima,T Tanaka,T Ohse,H Kato,T Fujita,M Nangaku,I Kojima,T Tanaka,T Ohse,H Kato,T Fujita,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Recent patents on cardiovascular drug discovery

VOLUME: 1

Page Numbers: 126-9

Journal Abbreviation:

ISSN: 1574-8901

DAY: 28

MONTH: Jun

YEAR: 2006

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101263805

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase.

AFFILIATION: Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. mnangaku-tky@umin.ac.jp.

Country: United Arab Emirates

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Patents Cardiovasc Drug

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase Related Publications

• A carrier for clinical use of recombinant human BMP-2: dehydrothermally cross-linked composite of fibrillar and denatured atelocollagen sponge.
• A case of Weber-Christian disease associated with myelodysplastic syndrome.
• A vector-selective reaction enables efficient construction of specific topology upon the primary side of beta-cyclodextrin.
• Angiotensin II type 1 receptor blockade prevents decrease in adult stem-like cells in kidney after ureteral obstruction.
• ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases.
• Association between Strongyloides stercoralis infection and biliary tract cancer.
• Automated detection algorithm for arteriolar narrowing on fundus images.
• Convenient preparative method for lactones from 3-hydroxy propanoic acids using iodine under solvent-free conditions.
• Correlation between the antitumor activity of a polysaccharide schizophyllan and its triple-helical conformation in dilute aqueous solution.
• Dendritic cells: nature and classification.
• Depression of sink activity precedes the inhibition of biomass production in tomato plants subjected to potassium deficiency stress.
• Dual regulation of the Bacillus subtilis regulon comprising the lmrAB and yxaGH operons and yxaF gene by two transcriptional repressors, LmrA and YxaF, in response to flavonoids.
• Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.
• Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
• Generation of a prophylactic melanoma vaccine using whole recombinant yeast expressing MART-1.
• Glycopeptide pharmacokinetics in current paediatric cardiac surgery practice.
• Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation.
• Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury.
• Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2.
• Iridoid Glucosides of Melampyrum laxum.
• Munchausen syndrome with foreign-body granuloma mimicking rheumatic diseases.
• Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia.
• Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer (Br J Surg 2007; 94: 1028-1032).
• Prevalence of Blastocystis hominis and Strongyloides stercoralis infection in Okinawa, Japan.
• RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity.
• Ru(ii)-cornered coordination cage that senses guest inclusion by color change.
• Significance of endotoxaemia in chronic kidney disease.
• Structure Elucidation of Longikaurin G: A New Minor Diterpenoid from Rabdosia longituba.
• The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
• The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor.